Logo image of SG

SWEETGREEN INC - CLASS A (SG) Stock Fundamental Analysis

NYSE:SG - New York Stock Exchange, Inc. - US87043Q1085 - Common Stock - Currency: USD

13  -0.56 (-4.13%)

Premarket: 13.04 +0.04 (+0.31%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to SG. SG was compared to 132 industry peers in the Hotels, Restaurants & Leisure industry. While SG seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, SG is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

SG had negative earnings in the past year.
SG had a positive operating cash flow in the past year.
In the past 5 years SG always reported negative net income.
In multiple years SG reported negative operating cash flow during the last 5 years.
SG Yearly Net Income VS EBIT VS OCF VS FCFSG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

The Return On Assets of SG (-10.71%) is worse than 84.09% of its industry peers.
With a Return On Equity value of -20.65%, SG perfoms like the industry average, outperforming 40.15% of the companies in the same industry.
Industry RankSector Rank
ROA -10.71%
ROE -20.65%
ROIC N/A
ROA(3y)-14.91%
ROA(5y)-23.59%
ROE(3y)-26.31%
ROE(5y)-34.72%
ROIC(3y)N/A
ROIC(5y)N/A
SG Yearly ROA, ROE, ROICSG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60

1.3 Margins

SG has a Gross Margin of 28.44%. This is in the lower half of the industry: SG underperforms 78.79% of its industry peers.
SG's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for SG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 28.44%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.09%
GM growth 5Y-0.69%
SG Yearly Profit, Operating, Gross MarginsSG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

More info and screens

6

2. Health

2.1 Basic Checks

SG does not have a ROIC to compare to the WACC, probably because it is not profitable.
SG has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, SG has more shares outstanding
SG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SG Yearly Shares OutstandingSG Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
SG Yearly Total Debt VS Total AssetsSG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 1.38, we must say that SG is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of SG (1.38) is comparable to the rest of the industry.
SG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.38
ROIC/WACCN/A
WACC9.29%
SG Yearly LT Debt VS Equity VS FCFSG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 1.97 indicates that SG should not have too much problems paying its short term obligations.
SG has a better Current ratio (1.97) than 84.09% of its industry peers.
SG has a Quick Ratio of 1.95. This is a normal value and indicates that SG is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Quick ratio value of 1.95, SG belongs to the best of the industry, outperforming 84.85% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.97
Quick Ratio 1.95
SG Yearly Current Assets VS Current LiabilitesSG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

5

3. Growth

3.1 Past

SG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.47%, which is quite good.
Looking at the last year, SG shows a quite strong growth in Revenue. The Revenue has grown by 11.11% in the last year.
The Revenue has been growing by 19.81% on average over the past years. This is quite good.
EPS 1Y (TTM)10.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.7%
Revenue 1Y (TTM)11.11%
Revenue growth 3Y25.81%
Revenue growth 5Y19.81%
Sales Q2Q%5.36%

3.2 Future

SG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.31% yearly.
The Revenue is expected to grow by 15.66% on average over the next years. This is quite good.
EPS Next Y16.81%
EPS Next 2Y17.47%
EPS Next 3Y17.04%
EPS Next 5Y17.31%
Revenue Next Year10.12%
Revenue Next 2Y14.95%
Revenue Next 3Y16.23%
Revenue Next 5Y15.66%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
SG Yearly Revenue VS EstimatesSG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B 2.5B
SG Yearly EPS VS EstimatesSG Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -2 -4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SG. In the last year negative earnings were reported.
Also next year SG is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SG Price Earnings VS Forward Price EarningsSG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SG Per share dataSG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

A more expensive valuation may be justified as SG's earnings are expected to grow with 17.04% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.47%
EPS Next 3Y17.04%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SWEETGREEN INC - CLASS A

NYSE:SG (7/15/2025, 8:22:08 PM)

Premarket: 13.04 +0.04 (+0.31%)

13

-0.56 (-4.13%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)08-07 2025-08-07/amc
Inst Owners108.27%
Inst Owner Change0%
Ins Owners1.49%
Ins Owner Change0.15%
Market Cap1.53B
Analysts80
Price Target23.65 (81.92%)
Short Float %18.2%
Short Ratio3.44
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.76%
Min EPS beat(2)-14.78%
Max EPS beat(2)9.26%
EPS beat(4)1
Avg EPS beat(4)-16.17%
Min EPS beat(4)-32.59%
Max EPS beat(4)9.26%
EPS beat(8)2
Avg EPS beat(8)-15.06%
EPS beat(12)5
Avg EPS beat(12)-9.11%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.86%
Min Revenue beat(2)-3.52%
Max Revenue beat(2)-2.2%
Revenue beat(4)0
Avg Revenue beat(4)-2.62%
Min Revenue beat(4)-3.91%
Max Revenue beat(4)-0.84%
Revenue beat(8)1
Avg Revenue beat(8)-2.61%
Revenue beat(12)1
Avg Revenue beat(12)-3.84%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-8.49%
PT rev (3m)-28.79%
EPS NQ rev (1m)-3.85%
EPS NQ rev (3m)-71.22%
EPS NY rev (1m)-1.68%
EPS NY rev (3m)-8.05%
Revenue NQ rev (1m)-0.3%
Revenue NQ rev (3m)-6.1%
Revenue NY rev (1m)-0.34%
Revenue NY rev (3m)-2.64%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.23
P/FCF N/A
P/OCF 57
P/B 3.53
P/tB 4.1
EV/EBITDA N/A
EPS(TTM)-0.77
EYN/A
EPS(NY)-0.49
Fwd EYN/A
FCF(TTM)-0.59
FCFYN/A
OCF(TTM)0.23
OCFY1.75%
SpS5.82
BVpS3.68
TBVpS3.17
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.71%
ROE -20.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 28.44%
FCFM N/A
ROA(3y)-14.91%
ROA(5y)-23.59%
ROE(3y)-26.31%
ROE(5y)-34.72%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.09%
GM growth 5Y-0.69%
F-Score6
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 141.72%
Cap/Sales 14.07%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.97
Quick Ratio 1.95
Altman-Z 1.38
F-Score6
WACC9.29%
ROIC/WACCN/A
Cap/Depr(3y)172.66%
Cap/Depr(5y)198.17%
Cap/Sales(3y)17.26%
Cap/Sales(5y)20.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.7%
EPS Next Y16.81%
EPS Next 2Y17.47%
EPS Next 3Y17.04%
EPS Next 5Y17.31%
Revenue 1Y (TTM)11.11%
Revenue growth 3Y25.81%
Revenue growth 5Y19.81%
Sales Q2Q%5.36%
Revenue Next Year10.12%
Revenue Next 2Y14.95%
Revenue Next 3Y16.23%
Revenue Next 5Y15.66%
EBIT growth 1Y12.42%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year135.06%
EBIT Next 3Y47.21%
EBIT Next 5Y32.71%
FCF growth 1Y51.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y192.51%
OCF growth 3YN/A
OCF growth 5YN/A